NO20032286L - Anvendelse av ClyA hemolysin for ekskresjon av proteiner - Google Patents

Anvendelse av ClyA hemolysin for ekskresjon av proteiner

Info

Publication number
NO20032286L
NO20032286L NO20032286A NO20032286A NO20032286L NO 20032286 L NO20032286 L NO 20032286L NO 20032286 A NO20032286 A NO 20032286A NO 20032286 A NO20032286 A NO 20032286A NO 20032286 L NO20032286 L NO 20032286L
Authority
NO
Norway
Prior art keywords
clya
hemolysin
protein
protein excretion
protein export
Prior art date
Application number
NO20032286A
Other languages
English (en)
Other versions
NO20032286D0 (no
Inventor
James E Galen
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of NO20032286D0 publication Critical patent/NO20032286D0/no
Publication of NO20032286L publication Critical patent/NO20032286L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO20032286A 2000-11-22 2003-05-21 Anvendelse av ClyA hemolysin for ekskresjon av proteiner NO20032286L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25251600P 2000-11-22 2000-11-22
PCT/US2001/044185 WO2002083890A2 (en) 2000-11-22 2001-11-23 Use of clya hemolysin for excretion of fusion proteins

Publications (2)

Publication Number Publication Date
NO20032286D0 NO20032286D0 (no) 2003-05-21
NO20032286L true NO20032286L (no) 2003-07-07

Family

ID=22956340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032286A NO20032286L (no) 2000-11-22 2003-05-21 Anvendelse av ClyA hemolysin for ekskresjon av proteiner

Country Status (16)

Country Link
US (2) US7056700B2 (no)
EP (1) EP1412502B1 (no)
JP (1) JP3976685B2 (no)
AT (1) ATE474926T1 (no)
AU (1) AU2001297770B2 (no)
CA (1) CA2430322A1 (no)
CZ (1) CZ20031378A3 (no)
DE (1) DE60142646D1 (no)
ES (1) ES2349114T3 (no)
HU (1) HUP0303843A3 (no)
MX (1) MXPA03004562A (no)
NO (1) NO20032286L (no)
NZ (1) NZ525735A (no)
PL (1) PL366122A1 (no)
WO (1) WO2002083890A2 (no)
ZA (1) ZA200303851B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208653A1 (de) * 2002-02-28 2003-09-18 Medinnova Ges Med Innovationen Mikroorganismus als Träger von Nukleotidsequenzen kodierend für Zellantigene zur Behandlung von Tumoren
US20080124355A1 (en) * 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
CN101827943B (zh) 2007-05-22 2016-04-13 康乃尔研究基金会有限公司 蛋白质在细菌及其衍生小泡表面展示的组合物和方法及其用途
CN105950608B (zh) * 2007-05-22 2019-12-17 康乃尔研究基金会有限公司 蛋白质在细菌及其衍生小泡表面展示的组合物和方法及其用途
EP2294090B1 (en) 2008-06-03 2014-05-14 University of Maryland, Baltimore NON-HEMOLYTIC ClyA FOR EXCRETION OF PROTEINS
CA2733425A1 (en) * 2008-08-06 2010-02-11 Emergent Product Development Uk Limited Vaccines against clostridium difficile and methods of use
US20100042072A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US20100040546A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US10046040B2 (en) * 2009-11-16 2018-08-14 University Of Maryland, Baltimore Multivalent live vector vaccine against Clostridium difficile-associated disease
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
WO2013151706A2 (en) 2012-04-06 2013-10-10 Cornell University Subunit vaccine delivery platform for robust humoral and cellular immune responses
BR112016022447A2 (pt) * 2014-03-28 2017-10-10 Novozymes As ressolubilização de cristais de proteína a ph baixo
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
MY193736A (en) 2017-11-03 2022-10-27 Takeda Vaccines Inc Method for inactivating zika virus and for determining the completeness of inactivation
CN110747155A (zh) * 2019-11-12 2020-02-04 湖南大学 减毒重组工程菌及其制备方法、应用和肿瘤靶向药物
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) * 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
US4355117A (en) * 1980-10-08 1982-10-19 Nabisco Brands, Inc. Process for preparing agglomerated fibrous cellulose
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4665027A (en) * 1983-11-03 1987-05-12 Bio-Process Innovation, Inc. Immobilized cell reactor-separator with simultaneous product separation and methods for design and use thereof
US5387744A (en) * 1987-06-04 1995-02-07 Washington University Avirulent microbes and uses therefor: Salmonella typhi
KR890005273A (ko) * 1987-09-09 1989-05-13 이정오 2중 실관 반응기에 의한 구연산의 연속 생산방법
DE4239612A1 (de) * 1992-11-25 1994-05-26 Cultor Oy Bioreaktor mit immobilisierten, Milchsäure-produzierenden Bakterien und dessen Verwendung in Fermentationsverfahren
US5525504A (en) * 1993-04-30 1996-06-11 Merck Patent Gesellschaft Mit Beschrankter Haftung Cytolysin gene and gene product
WO1994028137A1 (en) * 1993-05-24 1994-12-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Regulator of contact-mediated hemolysin
US5512480A (en) * 1994-03-11 1996-04-30 Baxter International Inc. Flow-through bioreactor with grooves for cell retention
US5585266A (en) * 1995-10-05 1996-12-17 Plitt; Cheryl A. Immobilized cell bioreactor
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
US7056700B2 (en) 2006-06-06
ATE474926T1 (de) 2010-08-15
EP1412502B1 (en) 2010-07-21
US20060147461A1 (en) 2006-07-06
NO20032286D0 (no) 2003-05-21
NZ525735A (en) 2005-07-29
JP2004532634A (ja) 2004-10-28
EP1412502A2 (en) 2004-04-28
MXPA03004562A (es) 2003-09-10
DE60142646D1 (en) 2010-09-02
WO2002083890A2 (en) 2002-10-24
HUP0303843A3 (en) 2010-01-28
WO2002083890A3 (en) 2004-02-26
HUP0303843A2 (hu) 2004-03-01
ZA200303851B (en) 2004-05-11
CZ20031378A3 (cs) 2003-09-17
CA2430322A1 (en) 2002-10-24
AU2001297770B2 (en) 2007-04-05
JP3976685B2 (ja) 2007-09-19
US7459161B2 (en) 2008-12-02
US20020146430A1 (en) 2002-10-10
PL366122A1 (en) 2005-01-24
ES2349114T3 (es) 2010-12-28

Similar Documents

Publication Publication Date Title
NO20032286L (no) Anvendelse av ClyA hemolysin for ekskresjon av proteiner
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
WO2001064835A8 (en) Novel nucleic acids and polypeptides
ATE500323T1 (de) Subtilisin-variante
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
CY1109207T1 (el) Διαδικασια εχινοκανδινης
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
ATE356881T1 (de) Expression von alkalischer phosphatase in hefe
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
WO2001064834A8 (en) Novel nucleic acids and polypeptides
EA200702092A1 (ru) Липосомная композиция для индукции иммунитета
ATE321853T1 (de) Humanische pellino-polypeptide
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
SE9602822D0 (sv) New receptor
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
BR0111983A (pt) métodos e substratos de peptìdeo de metaloprotease
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
TR199902605T2 (xx) Fibrinojenin azalt�lma y�ntemleri.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application